---
trial_id: 655
discovery_date: 2022-04-15 12:12:54.166601
date: 2022-04-15 12:12:54.166601
title: "A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab (6mg) in Patients With Neovascular Age-related Macular Degeneration (nAMD)"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04632056'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
